XML 111 R80.htm IDEA: XBRL DOCUMENT
v3.26.1

Share-based payments - Narrative (Details) € in Thousands, $ in Millions |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 Months Ended | 2 Months Ended | 6 Months Ended | 7 Months Ended | 10 Months Ended | 12 Months Ended | 30 Months Ended | 110 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Nov. 13, 2025 shares | Aug. 01, 2025 shares | May 30, 2025 shares | Apr. 22, 2025 shares | Mar. 20, 2025 shares | Feb. 06, 2025 shares | Sep. 05, 2024 shares | Jul. 11, 2024 shares | May 23, 2024 shares | Mar. 28, 2024 shares | Jan. 02, 2024 shares | Dec. 01, 2023 shares | Sep. 28, 2023 shares | Jul. 11, 2023 USD ($) shares | Apr. 30, 2025 shares | Mar. 31, 2025 shares | Jan. 31, 2025 shares | Mar. 31, 2024 shares | Dec. 01, 2023 USD ($) shares | Dec. 31, 2023 EUR (€) shares | Sep. 05, 2024 | Nov. 30, 2025 shares | Dec. 31, 2025 EUR (€) shares | Dec. 31, 2023 EUR (€) | Dec. 31, 2025 EUR (€) shares | Dec. 31, 2025 EUR (€) shares | Dec. 31, 2024 EUR (€)
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Provisions | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 0 |  |  | € 17,030 | € 0 | € 17,030 | € 17,030 | € 532
Other non-current provisions | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 30 |  |  | € 28,849 | € 30 | € 28,849 | € 28,849 | € 819
Total BCEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change of control, minimum percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50.00% |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |  |  | 496,965 |
BCE except BCE 2014-2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Performance conditions, minimum financing | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 100,000 |  |  |  |
Total BSAs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change of control, minimum percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50.00% |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 39,370 |  | 125,000 |  |  |  |  |  | 164,370 |  |  | 486,714 |
BSA-2024-1 and BSA-2024-2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 77,820 |  |  |  |  |  |  |  |  |
BSA-2025-1 and BSA-2025-2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 125,000 |  |  |  |  |  |  |  |  |  |
BSA-2025-3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  | 39,370 |  |  |  |  |  |  |  |  |  |  | 39,370 |  |  |  |  |  |  |  | 39,370 |  |  |  |
Total AGAs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,601,296 |  |  | 6,280,727 |  | 10,828,148 |  |
Provisions | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 16,467 |  | € 16,467 | € 16,467 |
Other non-current provisions | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 28,718 |  | € 28,718 | € 28,718 |
AGA-2023-1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,382,796 |  |  |  |  |  |  |  |  | 0 |  |  |  |
AGA-2023-1 | Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,382,796 |  |  |  |  |  |  |  |  |  |  |  |  |
AGA-2023-2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 |  |  |  |  |  |  |  |  | 0 |  |  |  |
AGA-2023-2 | Former Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 |  |  |  |  |  |  |  |  |  |  |  |  |
AGA-2023-3 , AGA-2023-4 and AGA-2023-5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Performance conditions, minimum financing | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 200 |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,118,500 |  |  |  |  |  |  |  |
Number of instruments issued subject to non-market performance condition (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 254,250 |  |  |  |  |  |  |  |
AGA-2023-3 and AGA-2023-4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  | 985,750 |  |  |  |  |  |  |  |  |  |  |  |  |  |
AGA-2023-5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  | 132,750 |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  |
AGA-2024-1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  | 1,549,125 |  |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  |
AGA-2024-2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  | 22,500 |  |  |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  |
AGA-2024-3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  | 38,500 |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  |
AGA-2024-4, AGA-2024-5 and AGA-2024-6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  | 138,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AGA-2024-7 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  | 198,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  |
AGA-2024-6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  | 20,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  |
AGA-2024-6 | Employee |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  | 20,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AGA-2025-1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  | 4,319,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,319,500 | 4,319,500 |  |  |  |
AGA-2025-2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  | 123,102 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 123,102 | 123,102 |  |  |  |
AGA-2025-3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  | 17,625 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,625 | 17,625 |  |  |  |
AGA-2025-4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  | 30,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30,500 | 30,500 |  |  |  |
AGA-2025-6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  | 25,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25,000 | 25,000 |  |  |  |
AGA-2025-7 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  | 1,711,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,711,000 | 1,711,000 |  |  |  |
AGA-2025-8 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) | 4,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,000 | 4,000 |  |  |  |
AGA-2025-5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  |  | 50,000 |  |  |  |  |  | 50,000 | 50,000 |  |  |  |
Tranche 1 | Total BCEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |
Tranche 1 | Total BSAs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |
Tranche 1 | AGA-2023-1 | Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 212,738 |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 1 | AGA-2023-2 | Former Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 25,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 1 | AGA-2023-3 , AGA-2023-4 and AGA-2023-5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50.00% |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years |  |  |  |  |  |  |  |
Tranche 1 | AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50.00% |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years |  |  |  |  |  |
Tranche 1 | AGA-2024-6 | Employee |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  | 10,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 1 | AGA-2025-1, AGA-2025-3, AGA-2025-4, AGA-2025-6, AGA-2025-7 and AGA-2025-8 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50.00% |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years |  |  |  |  |
Tranche 2 | Total BCEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 75.00% |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |
Vesting percentage per month |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.0833% |  |  |  |
Tranche 2 | Total BSAs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 75.00% |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |
Vesting percentage per month |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.0833% |  |  |  |
Tranche 2 | AGA-2023-1 | Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 638,214 |  |  |  |  |  |  |  |  |  |  |  |  |
Service period |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 2 | AGA-2023-2 | Former Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 75,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 2 | AGA-2023-2 | Former Chief Executive Officer | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 2 | AGA-2023-3 , AGA-2023-4 and AGA-2023-5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |
Tranche 2 | AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |
Tranche 2 | AGA-2024-6 | Employee |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  | 10,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 2 | AGA-2025-1, AGA-2025-3, AGA-2025-4, AGA-2025-6, AGA-2025-7 and AGA-2025-8 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years |  |  |  |  |
Tranche 3 | AGA-2023-1 | Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 212,738 |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 3 | AGA-2023-1 | Chief Executive Officer | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 3 | AGA-2023-3 , AGA-2023-4 and AGA-2023-5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |  |  |
Tranche 3 | AGA-2024-1, AGE-2024-2, AGA-2024-3, AGA-2024-4, AGA-2024-5 and AGA-2024-7 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |
Tranche 3 | AGA-2025-1, AGA-2025-3, AGA-2025-4, AGA-2025-6, AGA-2025-7 and AGA-2025-8 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |
Tranche 4 | AGA-2023-1 | Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Performance conditions, minimum financing | $ |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 100 |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 106,369 |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 4 | AGA-2023-1 | Chief Executive Officer | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 5 | AGA-2023-1 | Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 106,369 |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 5 | AGA-2023-1 | Chief Executive Officer | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche 6 | AGA-2023-1 | Chief Executive Officer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 106,368 |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Number Of Other Equity Instruments Granted Subject To Non-Market Performance Condition + References No definition available. + Details
Name: | abvx_NumberOfOtherEquityInstrumentsGrantedSubjectToNonMarketPerformanceCondition
Namespace Prefix: | abvx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Vesting Requirements For Share-Based Payment Arrangement, Change Of Control, Minimum Threshold + References No definition available. + Details
Name: | abvx_VestingRequirementsForShareBasedPaymentArrangementChangeOfControlMinimumThreshold
Namespace Prefix: | abvx_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Vesting Requirements For Share-Based Payment Arrangement, Performance Conditions, Minimum Financing + References No definition available. + Details
Name: | abvx_VestingRequirementsForShareBasedPaymentArrangementPerformanceConditionsMinimumFinancing
Namespace Prefix: | abvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Vesting Requirements For Share-Based Payment Arrangement, Service Period + References No definition available. + Details
Name: | abvx_VestingRequirementsForShareBasedPaymentArrangementServicePeriod
Namespace Prefix: | abvx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage + References No definition available. + Details
Name: | abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentage
Namespace Prefix: | abvx_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Vesting Requirements For Share-Based Payment Arrangement, Vesting Percentage Per Month + References No definition available. + Details
Name: | abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPercentagePerMonth
Namespace Prefix: | abvx_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Vesting Requirements For Share-Based Payment Arrangement, Vesting Period + References No definition available. + Details
Name: | abvx_VestingRequirementsForShareBasedPaymentArrangementVestingPeriod
Namespace Prefix: | abvx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B9 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_e&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 78 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_OtherLongtermProvisions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of current provisions other than provisions for employee benefits. [Refer: Provisions] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B9 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_e&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 78 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_OtherShorttermProvisions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FoundersShareSubscriptionWarrantsBCEMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BCEExceptBCE20142Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_ShareSubscriptionWarrantsBSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20241AndBSA20242Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20251AndBSA20252Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_BSA20253Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=abvx_FormerChiefExecutiveOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233AGA20234AndAGA20235Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233AndAGA20234Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244AGA20245AndAGA20246Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=abvx_EmployeeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20251Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20252Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20253Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20254Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20256Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20257Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20258Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20255Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | abvx_TranchesAxis=abvx_TrancheOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241AGE20242AGA20243AGA20244AGA20245AndAGA20247Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20251AGA20253AGA20254AGA20256AGA20257AndAGA20258Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | abvx_TranchesAxis=abvx_TrancheTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | abvx_TranchesAxis=abvx_TrancheThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | abvx_TranchesAxis=abvx_TrancheFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | abvx_TranchesAxis=abvx_TrancheFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | abvx_TranchesAxis=abvx_TrancheSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |